Rhumbline Advisers Sanara Med Tech Inc. Transaction History
Rhumbline Advisers
- $104 Billion
- Q1 2025
A detailed history of Rhumbline Advisers transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 3,714 shares of SMTI stock, worth $114,799. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,714
Previous 3,231
14.95%
Holding current value
$114,799
Previous $107,000
7.48%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SMTI
# of Institutions
48Shares Held
917KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA201KShares$6.21 Million0.0% of portfolio
-
Black Rock Inc. New York, NY197KShares$6.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.9KShares$2.72 Million0.0% of portfolio
-
State Street Corp Boston, MA64.2KShares$1.98 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL40.8KShares$1.26 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $257M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...